Innovent Biologics, Inc. (HKG:1801)
Hong Kong · Delayed Price · Currency is HKD 102.40
+1.20 (1.19%)
Aug 21, 2026, 4:08 PM HKT
Innovent Biologics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| DBS | DBS | Buy Initiates $144.00 | Buy | Initiates | $144.00 | +40.62% | Aug 18, 2026 |
Unknown Analyst Daiwa No rating | Daiwa | Buy Maintains $120.00 | Buy | Maintains | $120.00 | +17.19% | Aug 12, 2026 |
Unknown Analyst BOCOM International Holdings Company No rating | BOCOM International Holdings Company | Buy Maintains $105.00 → $118.00 | Buy | Maintains | $105.00 → $118.00 | +15.23% | Aug 7, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $117.00 | Buy | Maintains | $117.00 | +14.26% | Aug 6, 2026 |
Unknown Analyst UOB Kay Hian No rating | UOB Kay Hian | Buy Maintains $112.00 | Buy | Maintains | $112.00 | +9.37% | Jul 16, 2026 |
Unknown Analyst CLSA No rating | CLSA | Buy Maintains $139.90 | Buy | Maintains | $139.90 | +36.62% | Jul 15, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Maintains $124.00 → $124.10 | Buy | Maintains | $124.00 → $124.10 | +21.19% | Jul 14, 2026 |
Unknown Analyst Zhongtai Securities No rating | Zhongtai Securities | Buy Maintains $134.50 | Buy | Maintains | $134.50 | +31.35% | Jul 11, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.